We are live on !
Find out more
Marshall Wace Portfolio holdings
AUM
$127B
Turnover
40.17%
1-Year Est. Return
46.06%
This Fund
S&P 500
This Quarter Est. Return
+26.15%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$127B
AUM Growth
+$26.3B
(+26%)
Cap. Flow
+$9.28B
Cap. Flow % of AUM
Cap. Flow %
7.32%
Top 10 Holdings %
Top 10 Hldgs %
37.66%
Holding
3,898
New
771
Increased
1,083
Reduced
1,182
Closed
795
Avg Time Held
Equity + Options
1
year
Top 10 Avg Time Held
Equity + Options
2.3
years
Top 20 Avg Time Held
Equity + Options
1.6
years
Avg Time Held Equity only
1
year
Top 10 Avg Time Held Equity only
2.4
years
Top 20 Avg Time Held Equity only
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.9B |
| 2 |
Costco
COST
|
+$907M |
| 3 |
AbbVie
ABBV
|
+$643M |
| 4 |
JPMorgan Chase
JPM
|
+$609M |
| 5 |
Bank of America
BAC
|
+$567M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Mercado Libre
MELI
|
+$528M |
| 3 |
Broadcom
AVGO
|
+$514M |
| 4 |
Sandisk
SNDK
|
+$507M |
| 5 |
Marvell Technology
MRVL
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.91% |
| 2 | Technology | 20.64% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Healthcare | 8.21% |
| 5 | Financials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
301
Coupang
CPNG
$24.7B
| $62.4M | 0.05% |
+3,591,049
| New | +$64.8M |
2026 Q2
0 quarters
|
|
302
Mastercard
MA
$538B
| $62.3M | 0.05% |
121,391
+106,655
| +724% | +$53.2M |
2025 Q1
5 quarters
|
|
303
PUT
DraftKings
DKNG
$10.3B
| $62.3M | 0.05% |
+2,467,000
| New | +$60.8M |
2026 Q2
0 quarters
|
|
304
Wabtec
WAB
$46.9B
| $62M | 0.05% |
230,000
+75,000
| +48% | +$19.8M |
2026 Q1
1 quarter
|
|
305
Pultegroup
PHM
$23.1B
| $61.9M | 0.05% |
451,257
+205,952
| +84% | +$25M |
2026 Q1
1 quarter
|
|
306
Compass Pathways
CMPS
$1.55B
| $61.3M | 0.05% |
4,328,682
+290,347
| +7% | +$2.95M |
2026 Q1
1 quarter
|
|
307
Vanguard Morningstar Value ETF
VTV
$193B
| $61.2M | 0.05% |
+280,670
| New | +$58.6M |
2026 Q2
0 quarters
|
|
308
Definium Therapeutics
DFTX
$4.87B
| $61.1M | 0.05% |
1,298,946
+98,121
| +8% | +$2.42M |
2024 Q1
9 quarters
|
|
309
TE Connectivity
TEL
$62.3B
| $61M | 0.05% |
302,800
-73,776
| -20% | -$15.7M |
2023 Q3
11 quarters
|
|
310
Ralph Lauren
RL
$23B
| $60.2M | 0.05% |
149,919
+114,880
| +328% | +$42.8M |
2023 Q4
10 quarters
|
|
311
Valley National Bancorp
VLY
$7.81B
| $60M | 0.05% |
4,097,989
-436,238
| -10% | -$5.93M |
2024 Q2
8 quarters
|
|
312
NVR
NVR
$15.4B
| $60M | 0.05% |
8,803
+3,520
| +67% | +$22.4M |
2025 Q4
2 quarters
|
|
313
Arcus Biosciences
RCUS
$2.28B
| $60M | 0.05% |
1,945,088
-1,816,349
| -48% | -$44.9M |
2025 Q4
2 quarters
|
|
314
Petrobras
PBR
$144B
| $59.6M | 0.05% |
3,687,729
+757,743
| +26% | +$14.8M |
2025 Q2
4 quarters
|
|
315
CALL
Apple
AAPL
$5.02T
| $59.5M | 0.05% |
205,600
+101,700
| +98% | +$29.1M |
2025 Q3
3 quarters
|
|
316
Fifth Third Bancorp
FITB
$48.2B
| $59.4M | 0.05% |
1,053,650
+959,329
| +1,017% | +$48.6M |
2024 Q3
7 quarters
|
|
|
317
PUT
Apple
AAPL
$5.02T
| $59.3M | 0.05% |
205,000
+49,500
| +32% | +$14.2M |
2025 Q2
4 quarters
|
|
318
Nutanix
NTNX
$19.5B
| $58.9M | 0.05% |
1,155,042
+158,417
| +16% | +$7.16M |
2026 Q1
1 quarter
|
|
319
Toll Brothers
TOL
$13B
| $58.3M | 0.05% |
353,898
+132,667
| +60% | +$18.9M |
2025 Q3
3 quarters
|
|
320
Lam Research
LRCX
$300B
| $58.3M | 0.05% |
134,545
+15,654
| +13% | +$4.75M |
2025 Q1
5 quarters
|
|
321
Pinduoduo
PDD
$111B
| $57.9M | 0.05% |
759,453
+436,868
| +135% | +$40.4M |
2020 Q1
25 quarters
|
|
322
CALL
iShares Russell 2000 ETF
IWM
$74.6B
| $57.8M | 0.05% |
192,300
+156,800
| +442% | +$44.1M |
2022 Q3
15 quarters
|
|
323
AMC Entertainment Holdings
AMC
$2.57B
| $57.7M | 0.05% |
30,384,569
+29,861,927
| +5,714% | +$51.4M |
2024 Q2
8 quarters
|
|
324
BlackBerry
BB
$5.44B
| $57.7M | 0.05% |
+4,564,235
| New | +$31.9M |
2026 Q2
0 quarters
|
|
325
PTC Therapeutics
PTCT
$5.06B
| $57.5M | 0.05% |
704,787
+244,149
| +53% | +$17.6M |
2025 Q1
5 quarters
|
|
Similar funds
Marshall Wace's Q2 2026 Portfolio in Review
As of Q2 2026, Marshall Wace held 3,898 positions worth $127B, up 26% from $100B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Marshall Wace deployed $9.28B of net new capital in Q2 2026, opening 771 new positions and adding to 1,083 existing holdings. Its largest new stake was LPL Financial: 975,627 shares worth $275M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $1.03B trimmed.
- Marshall Wace's largest Q2 2026 buy was LPL Financial: 975,627 shares worth $275M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.9B increase.
- Marshall Wace's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.03B.
- Marshall Wace fully exited Merck in Q2 2026, selling an estimated $325M.
- Marshall Wace's ten largest holdings make up 38% of its $127B portfolio in Q2 2026.
- Marshall Wace opened 771 new positions and closed 795 in Q2 2026.
- Marshall Wace's portfolio value rose 26% quarter-over-quarter to $127B.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.